Loading

2025

Volume 3, Issue 1, p1-11

Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.

AI in addiction: Harnessing technology for diagnosis, prevention, and recovery: A narrative review

Addiction, both substance use and behavioral disorders, remains a significant global public health issue, affecting individuals, families, and societies. Traditional methods of addiction management struggle to meet the increasing demand for effective solutions. Artificial intelligence (AI) has emerged as a promising tool to address this challenge, offering innovative solutions across diagnosis, prevention, and recovery.

Addict Subst Abuse, 2025, Volume 3, Issue 1, p1-7 | DOI: 10.46439/addiction.3.008

Prevalence of screening positive for attention-deficit/hyperactivity disorder in adults seeking methadone for opioid use disorder

This study aimed to characterize the prevalence of screening positive for attention-deficit/hyperactivity disorder (ADHD) among patients seeking methadone treatment for opioid use disorder (OUD) at an opioid treatment program (OTP) to study the association between screening positivity and patient retention.

Addict Subst Abuse, 2025, Volume 3, Issue 1, p8-11 | DOI: 10.46439/addiction.3.009

Recommended Articles

Association between resilience promotion factors during childhood and risk of drug use disorder during adulthood

Few studies have been conducted on the relationship between “outside-residing” resilience characteristics and the risk of developing drug use disorder later in life. These characteristics include responsive and caring parenting, household routines involving regular family meals and bedtime routines, social support from peers, participation in organized activities, and religious service attendance.

Portrayal of substance use in media and its effects on substance use disorders among youth

A variety of behavioral, environmental, developmental, and genetic factors have been documented as contributing to the development of Substance use disorders (SUDs) in youth. For example, it has been suggested that things such as the perceived availability of substances, familial history of anti-social behavior, personal attitudes favorable towards drug use all have strong correlations to the development of substance use in youth.

Predictors of relapse in alcohol use disorder: identifying individuals most vulnerable to relapse

Alcohol Use Disorder (AUD) is described as a chronic relapsing condition with definitive behavioral markers and is characterized by repeated drug intake despite severe negative consequences [1]. With 12-month prevalence rates at 14% and lifetime estimates of 29% [2], it is clear that AUD adversely and substantially affects individual and societal health [3]. Recognized clinically as affecting decision making, relationships, and neurological function [4]

Detection of some synthetic cannabinoids (FUB-AMB and AB-FUBINACA) in blood and urine using Gas Chromatography-mass spectrometry liquid–liquid extraction

In recent years, various types of synthetic cannabinoids have become widely distributed and are causing social and health problems in most parts of the world. Synthetic cannabinoids are currently the largest group of new psychoactive substances. Those that have been subjected to legal control are replaced by newer controlled and uncontrolled substances.

Suicide, opioids, chronic pain, and mental health disorders: a narrative

Suicide rates are on the rise in the United States as is mortality associated with opioid toxicity. According to the Centers for Disease Control and Prevention, about 7% of opioid overdose deaths are suicide, but this number may be under-reported. Many people who use opioids or have opioid use disorder, (OUD), may have “passive” intentions to commit suicide that are difficult to quantify. Further, both chronic pain and mental health disorders are prevalent in those who use opioids, and both are independently associated with suicide. It appears that suicide is associated with a trio of interlocking risk factors: opioids and opioid use disorder, chronic pain, and psychiatric illness.

Filter ventilation and the risk associated with cigarette smoking

It has long been clear that cigarette smoking is causally linked to many diseases, particularly lung cancer, chronic obstructive pulmonary disease and various forms of cardiovascular disease. For lung cancer, for example, a meta-analysis my colleagues and I conducted, based on epidemiological evidence published in the 1900s [1], estimated that current smoker/never smoker relative risks, were around 10 in North America

Clay eating in pregnancy in French Guiana: How does one understand the practices and act for prevention?

Geophagy is described in most countries of the world as a practice observed in pregnant women. In industrialized countries, it results from migrant populations who carry with them their cultural habits and practices. This is the case in France and more particularly in Guiana, an overseas territory. Originally used to treat the ills of pregnancy, it is today considered to be dangerous for the woman and her unborn child.

AI in addiction: Harnessing technology for diagnosis, prevention, and recovery: A narrative review

Addiction, both substance use and behavioral disorders, remains a significant global public health issue, affecting individuals, families, and societies. Traditional methods of addiction management struggle to meet the increasing demand for effective solutions. Artificial intelligence (AI) has emerged as a promising tool to address this challenge, offering innovative solutions across diagnosis, prevention, and recovery.

Prevalence of screening positive for attention-deficit/hyperactivity disorder in adults seeking methadone for opioid use disorder

This study aimed to characterize the prevalence of screening positive for attention-deficit/hyperactivity disorder (ADHD) among patients seeking methadone treatment for opioid use disorder (OUD) at an opioid treatment program (OTP) to study the association between screening positivity and patient retention.